Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 21-Oct-2017

Red Vascular Technology, LLC


The Next Generation of Branched Endografts

A challenging frontier for aortic endovascular repair are complex aortic aneurysms, those involving the origins of major arterial branches of the Thoracic and Abdominal Aorta. Through its patented technology, Red Vascular Technologies LLC meets this challenge in the next generation of branched endografts. Our goal is to replace the current industry standard of fenestration, that is modular branched endoprosthesis with our one-piece non modular designs.


Additional Questions

Who is your customer?

Medical devices, no matter what category, are sold to the physicians that use them, Developing simple non intimidating procedures and the devices that help patients in a safe and efficient manner are the goal of our company

What problem does this idea/product solve or what market need does it serve?

The current Aortic Endografts that are FDA approved for the treatment of Aortic aneurysms (and those in trial) that treat disease that affect the origins of the major Aortic branches such as the Carotid or Renal arteries are all modular in design. That means that the Graft is constructed in situ by deploying the components piece by piece until the desired effect is accomplished to bypass the aneurysm by excluding it from the blood flow. Red Vascular through it's disruptive IP solves this problem in an elegant and efficient manner. By reducing the number of steps necessary to deploy these grafts, operative time and patient safety, as well as minimizing complications, is the goal. The entire graft including the branch or branches (as we can deploy multiple branches) can be deployed as one component and in an "off the shelf" manner and is protected by multiple granted patents. No other company either with FDA approval or in clinical trials has this ability

What attributes will make this idea/product successful? Why do you believe that those features will create success?

Advantages of the Red Vascular Technology device in comparison to the FDA approved devices and those in clinical trial internationally are the following: 1. Non Modular, which means no in situ construction of the graft. 2. No risk of device disruption, migration and leakage due to multiple parts. 3. In the Thoracic position where there is aneurysmal involvement of the major vessels, especially the Carotids, there is immediate flow to these vessels with minimal manipulation. 4. Branch or Branches act as immediate "Anchors" to prevent graft movement and intra-operative migration during initial deployment and chronically. 5. Simple intuitive deployment sequence which lowers complications and mechanical problems allowing for greater patient safety. 6. Single site (Femoral) Retrograde Deployment. Particularly important in the Thoracic Aortic Aneurysm procedures. 7. The ability to graft multiple vessels concurrently and in close proximity because of our patent pending design. 8. The Red Vascular Non Modular Branched Endoprosthesis and delivery system are designed to as an “Off the Shelf” device which can be used in any situation, even emergency, without the need for many weeks of custom design. Because of these eight distinctive advantages, Red Vascular Technology will be able to compete against the giants of the medical device industry due to our disruptive IP. Having been the inventor and Founder of the original Endologix (ELGX, nasdaq) my similar disruptive IP and technology brought us to international clinical trials within 18 months.

Explain how you (your team) will execute to make this idea/product successful? What gives you (your team) an advantage over others already in the market or new to this market?

The market is established and the expectation by the community of invasive medical specialists is awaiting a non intimidating simplified method to treat aneurysms that affect the major branches in an elegant and less complex fashion for the safety of the patients that need to under go treatment of this dangerous disease. Having at their disposal a device that can be utilized off the shelf, that is without tedious and complex preoperative evaluations, allows us to treat the most challenging situations effectively.